Last reviewed · How we verify
EPCAM-targeted CAR-T cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
EPCAM-targeted CAR-T cells (EPCAM-targeted CAR-T cells) — Sinobioway Cell Therapy Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| EPCAM-targeted CAR-T cells TARGET | EPCAM-targeted CAR-T cells | Sinobioway Cell Therapy Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- EPCAM-targeted CAR-T cells CI watch — RSS
- EPCAM-targeted CAR-T cells CI watch — Atom
- EPCAM-targeted CAR-T cells CI watch — JSON
- EPCAM-targeted CAR-T cells alone — RSS
Cite this brief
Drug Landscape (2026). EPCAM-targeted CAR-T cells — Competitive Intelligence Brief. https://druglandscape.com/ci/epcam-targeted-car-t-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab